STOCK TITAN

Verano Announces Conference Participation for January

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a leading multi-state cannabis operator, announced participation in key investment conferences. Aaron Miles, Chief Investment Officer, will present at the ICR Conference on January 9, 2023, at 4:00 p.m. ET. Additionally, George Archos, CEO, will join a virtual chat at Needham’s Annual Growth Conference on January 12, 2023, at 10:15 a.m. ET, followed by another virtual panel featuring Aaron Miles on the same day at 1:30 p.m. ET. Verano operates 14 production facilities across 13 U.S. states, focused on delivering premium cannabis products.

Positive
  • Participation in high-profile investor conferences may enhance visibility and investor interest.
  • Verano's extensive operational footprint across 14 U.S. states supports potential revenue growth.
  • The company maintains a diverse product portfolio addressing health and wellness needs.
Negative
  • No significant financial metrics or performance indicators were disclosed in the announcement.

CHICAGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will participate in the following conferences:

ICR Conference 2023
Aaron Miles, Chief Investment Officer, will give a presentation onsite in Orlando.
DATE: January 9, 2023
TIME: 4:00 p.m. ET

Needham’s 25th Annual Growth Conference
George Archos, Founder & Chief Executive Officer, will participate in a virtual fireside chat.
DATE: January 12, 2023
TIME: 10:15 a.m. ET

ATB’s 11th Annual Institutional Investor Conference
Aaron Miles, Chief Investment Officer, will participate in a virtual panel.
DATE: January 12, 2023
TIME: 1:30 p.m. ET

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia, BITS, Encore, MŪV and Savvy. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 14 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MŪV™, delivering a superior cannabis shopping experience in both medical and adult use markets. Learn more at www.verano.com.

Contacts:

Media
Verano
Steve Mazeika
Director, Communications
Steve.Mazeika@verano.com
312-348-4430

Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
investors@verano.com

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###


FAQ

What conferences is Verano Holdings participating in January 2023?

Verano Holdings is participating in the ICR Conference on January 9 and Needham’s Annual Growth Conference on January 12, 2023.

Who represents Verano Holdings at the ICR Conference?

Aaron Miles, Chief Investment Officer, will present at the ICR Conference.

When is George Archos speaking at the Needham’s Annual Growth Conference?

George Archos, CEO, will speak at 10:15 a.m. ET on January 12, 2023.

What is Verano's business focus?

Verano is focused on being a vertically integrated cannabis operator, providing regulated cannabis products across multiple states.

How many states does Verano operate in?

Verano operates in 14 U.S. states.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

610.70M
302.30M
15.59%
10.6%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago